Stehlík M, Kisel'ák J, Dinamarca A, Alvarado E, Plaza F, Medina F A, Stehlíková S, Marek J, Venegas B, Gajdoš A, Li Y, Katuščák S, Bražinová A, Zeintl E, Lu Y
Linz Institute of Technology & Department of Applied Statistics, J. Kepler University in Linz, Linz, Austria.
Instituto de Estadística, Universidad de Valparaíso, Valparaíso, Chile.
Stoch Anal Appl. 2023;41(3):474-508. doi: 10.1080/07362994.2022.2033126. Epub 2022 Feb 25.
As COVID-19 is spreading, national agencies need to monitor and track several metrics. Since we do not have perfect testing programs on the hand, one needs to develop an advanced sampling strategies for prevalence study, control and management. Here we introduce REDACS: Regional emergency-driven adaptive cluster sampling for effective COVID-19 management and control and justify its usage for COVID-19. We show its advantages over classical massive individual testing sampling plans. We also point out how regional and spatial heterogeneity underlines proper sampling. Fundamental importance of adaptive control parameters from emergency health stations and medical frontline is outlined. Since the Northern hemisphere entered Autumn and Winter season (this paper was originally submitted in November 2020), practical illustration from spatial heterogeneity of Chile (Southern hemisphere, which already experienced COVID-19 winter outbreak peak) is underlying the importance of proper regional heterogeneity of sampling plan. We explain the regional heterogeneity by microbiological backgrounds and link it to behavior of Lyapunov exponents. We also discuss screening by antigen tests from the perspective of "on the fly" biomarker validation, i.e., during the screening.
随着新冠病毒病(COVID-19)的传播,各国机构需要监测和跟踪多个指标。由于目前手头没有完美的检测方案,因此需要制定先进的抽样策略用于患病率研究、防控和管理。在此,我们介绍REDACS:用于COVID-19有效管控的区域应急驱动自适应整群抽样,并阐述其在COVID-19中的应用合理性。我们展示了它相对于传统大规模个体检测抽样方案的优势。我们还指出区域和空间异质性如何突出适当抽样的重要性。概述了来自应急卫生站和医疗前线的自适应控制参数的根本重要性。由于北半球进入秋冬季节(本文最初于2020年11月提交),来自智利(南半球,已经历COVID-19冬季疫情高峰)空间异质性的实际例证凸显了抽样方案适当区域异质性的重要性。我们从微生物学背景解释区域异质性,并将其与李雅普诺夫指数的行为联系起来。我们还从“即时”生物标志物验证的角度,即在筛查过程中,讨论抗原检测筛查。